{"transactions":[{"id":2040384,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-31T21:18:53.000Z","date":"2023-01-27","kind":"exercise","acquired":false,"shares":1233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 27, 2022 (the \"Grant Date\"), the reporting person was granted 4,933 restricted stock units, vesting in four equal installments on the anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 27, 2022 (the \"Grant Date\"), the reporting person was granted 4,933 restricted stock units, vesting in four equal installments on the anniversary of the grant date."}],"balance_after":3700,"derivative":{"underlying":"Common Stock","underlying_shares":1233},"source":{"system":"sec-edgar","filing":"0000899243-23-003085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000089924323003085/doc4.xml","form_type":"4"}},{"id":2040383,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-31T21:18:53.000Z","date":"2023-01-27","kind":"sale","acquired":false,"shares":441,"price":7.49,"value":3303.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1)."}],"balance_after":19760,"source":{"system":"sec-edgar","filing":"0000899243-23-003085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000089924323003085/doc4.xml","form_type":"4"}},{"id":2040382,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-31T21:18:53.000Z","date":"2023-01-27","kind":"exercise","acquired":true,"shares":1233,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 490 shares of common stock and 1,462 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 31, 2022 and November 30, 2022, respectively."}],"balance_after":20201,"source":{"system":"sec-edgar","filing":"0000899243-23-003085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000089924323003085/doc4.xml","form_type":"4"}},{"id":2062863,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2023-01-05T21:46:24.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":47555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the \"RSUs\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on the Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary."}],"balance_after":47555,"derivative":{"underlying":"Common Stock","underlying_shares":47555},"source":{"system":"sec-edgar","filing":"0000899243-23-001135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000089924323001135/doc4.xml","form_type":"4"}},{"id":2062862,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-01-05T21:46:24.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":95110,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 3, 2023 (the \"Grant Date\") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the Grant Date and 2.0833% of the original number of shares on the first day of each calendar month thereafter until the fourth such anniversary."}],"balance_after":95110,"derivative":{"exercise_price":5.62,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":95110},"source":{"system":"sec-edgar","filing":"0000899243-23-001135","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000089924323001135/doc4.xml","form_type":"4"}},{"id":2282364,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-05-04T16:40:24.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":296000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on May 2, 2022 and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":296000,"derivative":{"exercise_price":0.55,"expiration_date":"2032-05-02","underlying":"Common Stock","underlying_shares":296000},"source":{"system":"sec-edgar","filing":"0001209191-22-027118","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919122027118/doc4.xml","form_type":"4"}},{"id":2333380,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-15T17:14:35.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":11396,"price":1.1,"value":12535.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1)."}],"balance_after":255209,"source":{"system":"sec-edgar","filing":"0001209191-22-018885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919122018885/doc4.xml","form_type":"4"}},{"id":2333379,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-03-15T17:14:35.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":11269,"price":1.1,"value":12395.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,272 shares acquired by Mr. Morris under the Solid Biosciences Employee Stock Purchase Plan on November 30, 2021."}],"balance_after":266605,"source":{"system":"sec-edgar","filing":"0001209191-22-018885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919122018885/doc4.xml","form_type":"4"}},{"id":2421145,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2022-01-31T17:34:31.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuers common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on January 27, 2022 and vest on the same schedule as set forth in footnote (1) above."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on January 27, 2022 and vest on the same schedule as set forth in footnote (1) above."}],"balance_after":74000,"derivative":{"underlying":"Common Stock","underlying_shares":74000},"source":{"system":"sec-edgar","filing":"0001209191-22-005693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919122005693/doc4.xml","form_type":"4"}},{"id":2421144,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-01-31T17:34:31.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":148000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 27, 2022 and vests in four equal annual installments on the anniversary of the grant date."}],"balance_after":148000,"derivative":{"exercise_price":1.13,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":148000},"source":{"system":"sec-edgar","filing":"0001209191-22-005693","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919122005693/doc4.xml","form_type":"4"}},{"id":2789294,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-15T16:05:26.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":11699,"price":8.8459,"value":103488.1841,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1) adopted by the reporting person on May 15, 2020."}],"balance_after":275602,"source":{"system":"sec-edgar","filing":"0001209191-21-020433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919121020433/doc4.xml","form_type":"4"}},{"id":2789293,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-03-15T16:05:26.000Z","date":"2021-03-12","kind":"sale","acquired":false,"shares":11699,"price":8.8434,"value":103458.9366,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1) adopted by the reporting person on May 15, 2020."}],"balance_after":287301,"source":{"system":"sec-edgar","filing":"0001209191-21-020433","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919121020433/doc4.xml","form_type":"4"}},{"id":2890476,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2021-01-29T16:00:08.000Z","date":"2021-01-27","kind":"exercise","acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vested six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vested six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-21-006068","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919121006068/doc4.xml","form_type":"4"}},{"id":2890475,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-29T16:00:08.000Z","date":"2021-01-28","kind":"sale","acquired":false,"shares":3459,"price":6.1399,"value":21237.9141,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units."}],"balance_after":299000,"source":{"system":"sec-edgar","filing":"0001209191-21-006068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919121006068/doc4.xml","form_type":"4"}},{"id":2890474,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-01-29T16:00:08.000Z","date":"2021-01-27","kind":"exercise","acquired":true,"shares":11500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock units convert into common stock on a one-for-one basis."}],"balance_after":302459,"source":{"system":"sec-edgar","filing":"0001209191-21-006068","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919121006068/doc4.xml","form_type":"4"}},{"id":2893554,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-01-27T16:00:08.000Z","date":"2021-01-25","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 25, 2021 and vests in four equal annual installments on the anniversary of the grant date."}],"balance_after":175000,"derivative":{"exercise_price":6.8,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-21-005638","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919121005638/doc4.xml","form_type":"4"}},{"id":3074134,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Units","published_at":"2020-07-29T17:37:10.000Z","date":"2020-07-27","kind":"exercise","acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the\ngrant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 27, 2020, the reporting person was granted 23,000 restricted stock units, vesting in two equal installments. Fifty percent vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the\ngrant date"}],"balance_after":11500,"derivative":{"underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-20-043961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919120043961/doc4.xml","form_type":"4"}},{"id":3074133,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-29T17:37:10.000Z","date":"2020-07-28","kind":"sale","acquired":false,"shares":3591,"price":2.4197,"value":8689.1427,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units."}],"balance_after":290959,"source":{"system":"sec-edgar","filing":"0001209191-20-043961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919120043961/doc4.xml","form_type":"4"}},{"id":3074132,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-07-29T17:37:10.000Z","date":"2020-07-27","kind":"exercise","acquired":true,"shares":11500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock units convert into common stock on a one-for-one basis."}],"balance_after":294550,"source":{"system":"sec-edgar","filing":"0001209191-20-043961","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919120043961/doc4.xml","form_type":"4"}},{"id":3105656,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-06-18T18:04:02.000Z","date":"2020-06-16","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock. This grant will vest in two equal installments with the first fifty percent vesting on March 11, 2021 and the second fifty percent on March 11, 2022."}],"balance_after":283050,"source":{"system":"sec-edgar","filing":"0001209191-20-037691","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919120037691/doc4.xml","form_type":"4"}},{"id":3211299,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-03-13T16:49:23.000Z","date":"2020-03-11","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction is a grant of restricted stock units representing 75,000 shares of common stock.  This grant will vest evenly over 2 years with the first fifty percent vesting on the first anniversary of the grant date and the second fifty percent vesting on the second anniversary of the grant date."}],"balance_after":208050,"source":{"system":"sec-edgar","filing":"0001209191-20-018909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919120018909/doc4.xml","form_type":"4"}},{"id":3298823,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2020-01-29T17:34:54.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in 2 installments. Fifty percent will vest six months after the grant date with the remaining fifty percent vesting on the first anniversary of the grant date and will vest automatically as to 100% of the unvested portion of such restricted stock unit grant upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":23000,"derivative":{"exercise_price":0,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-20-005410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919120005410/doc4.xml","form_type":"4"}},{"id":3298822,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-01-29T17:34:54.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 27, 2020 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":47000,"derivative":{"exercise_price":3.47,"expiration_date":"2030-01-27","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001209191-20-005410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919120005410/doc4.xml","form_type":"4"}},{"id":3454339,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-07-29T16:28:09.000Z","date":"2019-07-25","kind":"grant","acquired":true,"shares":21505,"price":4.65,"value":99998.25,"ownership":{"direct":true},"balance_after":133050,"source":{"system":"sec-edgar","filing":"0001209191-19-043485","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000120919119043485/doc4.xml","form_type":"4"}},{"id":3686847,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock\nOption (Right to Buy)","published_at":"2019-01-25T17:06:21.000Z","date":"2019-01-23","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 23, 2019 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances."}],"balance_after":60000,"derivative":{"exercise_price":22.93,"expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-19-001957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000089924319001957/doc4.xml","form_type":"4"}},{"id":4055199,"issuer":{"id":4915,"kind":"organization","name":"Solid Biosciences Inc.","symbol":"SLDB"},"owners":[{"id":117476,"kind":"person","name":"Morris Carl Ashley","position":1,"cik":"0001727571","reported_name":"Morris Carl Ashley","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-02-15T20:29:35.000Z","date":"2018-02-14","kind":"grant","acquired":true,"shares":203858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in four equal installments beginning on February 14, 2019."}],"balance_after":203858,"derivative":{"exercise_price":26.23,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":203858},"source":{"system":"sec-edgar","filing":"0000899243-18-004343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727571/000089924318004343/doc4.xml","form_type":"4"}}]}